MET amplification has been detected in up to ~5 % [36, 39, 40], whereas an increased MET gene copy number was counted in ~20 % of patients with NSCLC by PCR based technique [37, 41–43]. The gene discussed is MET; the disease is non-small cell lung carcinoma.